Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Colorectal Neoplasms|Lung Neoplasms|Breast Neoplasms|Prostatic Neoplasms|Sarcoma
Interventions: DRUG: figitumumab|DRUG: pegvisomant
Sponsor: Pfizer